Russell Investments Group’s Ionis Pharmaceuticals IONS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$366K Buy
9,265
+3,512
+61% +$139K ﹤0.01% 2460
2025
Q1
$174K Sell
5,753
-56,447
-91% -$1.7M ﹤0.01% 2631
2024
Q4
$2.17M Sell
62,200
-66,269
-52% -$2.32M ﹤0.01% 1630
2024
Q3
$5.15M Sell
128,469
-4,267
-3% -$171K 0.01% 1167
2024
Q2
$6.33M Sell
132,736
-20,679
-13% -$986K 0.01% 1039
2024
Q1
$6.65M Sell
153,415
-4,387
-3% -$190K 0.01% 1036
2023
Q4
$7.98M Buy
157,802
+71,807
+84% +$3.63M 0.01% 900
2023
Q3
$3.9M Sell
85,995
-27,335
-24% -$1.24M 0.01% 1199
2023
Q2
$4.65M Buy
113,330
+9,854
+10% +$404K 0.01% 1130
2023
Q1
$3.7M Sell
103,476
-86,822
-46% -$3.1M 0.01% 1237
2022
Q4
$7.19M Buy
190,298
+97,978
+106% +$3.7M 0.01% 917
2022
Q3
$4.08M Sell
92,320
-6,914
-7% -$306K 0.01% 1160
2022
Q2
$3.67M Sell
99,234
-184,896
-65% -$6.84M 0.01% 1251
2022
Q1
$10.5M Buy
284,130
+89,985
+46% +$3.33M 0.02% 816
2021
Q4
$5.91M Sell
194,145
-37,720
-16% -$1.15M 0.01% 1158
2021
Q3
$7.77M Buy
231,865
+10,311
+5% +$346K 0.01% 1011
2021
Q2
$8.84M Buy
221,554
+190,623
+616% +$7.6M 0.01% 1000
2021
Q1
$1.39M Sell
30,931
-34,128
-52% -$1.53M ﹤0.01% 2094
2020
Q4
$3.68M Sell
65,059
-8,948
-12% -$506K 0.01% 1412
2020
Q3
$3.51M Sell
74,007
-7,324
-9% -$348K 0.01% 1334
2020
Q2
$4.79M Buy
81,331
+19,244
+31% +$1.13M 0.01% 1120
2020
Q1
$2.94M Buy
62,087
+39,963
+181% +$1.89M 0.01% 1259
2019
Q4
$1.33M Sell
22,124
-466
-2% -$28.1K ﹤0.01% 1960
2019
Q3
$1.35M Sell
22,590
-1,361
-6% -$81.5K ﹤0.01% 1863
2019
Q2
$1.54M Buy
23,951
+7,960
+50% +$512K ﹤0.01% 1794
2019
Q1
$1.3M Buy
15,991
+3,863
+32% +$314K ﹤0.01% 1928
2018
Q4
$656K Hold
12,128
﹤0.01% 2190
2018
Q3
$626K Hold
12,128
﹤0.01% 2293
2018
Q2
$505K Hold
12,128
﹤0.01% 2388
2018
Q1
$535K Sell
12,128
-177
-1% -$7.81K ﹤0.01% 2453
2017
Q4
$624K Hold
12,305
﹤0.01% 2357
2017
Q3
$624K Sell
12,305
-7,772
-39% -$394K ﹤0.01% 2357
2017
Q2
$1.02M Buy
20,077
+3,538
+21% +$180K ﹤0.01% 2103
2017
Q1
$665K Sell
16,539
-3,538
-18% -$142K ﹤0.01% 2311
2016
Q4
$976K Buy
+20,077
New +$976K ﹤0.01% 2184